Please assess the completion status of the following clinical trial:

Trial Title: Minimally Invasive Sensing of Beta-lactam Antibiotics

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adult \>18 years old~* Healthy with no evidence of active infection~* Previously received penicillin with no adverse effects~Exclusion Criteria:~* High risk of skin soft tissue infection or local skin and soft tissue infection near sensor site~* Previous history of allergies to adhesive strips or active dermatitis~* Penicillin allergy or previous adverse event whilst receiving penicillin~* Anaemia on screening bloods (defined as haemoglobin \<13 g/dL in males and \<12 g/dL in females)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Healthy volunteer (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).